J&J results top estimates, takes $13.6 billion tax charge
January 23, 2018 at 07:30 AM EST
(Reuters) - Johnson & Johnson reported adjusted quarterly profit and revenue slightly above analysts' expectations on Tuesday, as the healthcare company gained from strong demand for new drugs including cancer and psoriasis treatments.